glp-1 coverage 2026 Medicaid of and Spending on GLP-1s π As of early 2026,
Description
These insights are critical for safe and effective treatment
April 1, 2025
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin
In the Phase III NefIgArd trial, patients treated with Tarpeyo saw significantly better kidney function, as measured by the estimated glomerular filtration rate (eGFR) versus placebo after nine months on the drug and 15 months of follow-up
Vanessa Mack (Dean) Monitors Your Progress After the First Semaglutide GLP-1 Injection in Scottsdale, AZ Dr
Finally, theres a very common South American drink called yerba mate (from Argentina), a high-caffeine drink made with fermented tea leaves
